Ten of twelve PXA samples had an alteration in either BRAF or the mTOR pathway, in a mutually exclusive fashion, consistent with the idea that alterations of either one of these signaling cascades is required for tumorigenesis. The gene discussed is MTOR; the disease is pleomorphic xanthoastrocytoma.